Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 48, Issue 1, 2007, Pages 86-92

  Vilela, Maria Ivone Oliveira Pinto ^a,c   Viana, Marcos Borato ^b  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Ed Antonio Poteiro   (Brazil)

Author keywords

Acute lymphoblastic leukemia; Chemotherapy; Children; Growth; Height deficit; Radiotherapy

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BRAZIL; CANCER CHEMOTHERAPY; CATCH UP GROWTH; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; GROWTH DISORDER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SKULL IRRADIATION;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY HEIGHT; BRAZIL; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 33845338771     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20901     Document Type: Article

References (42)

1. Whitlock JM, Gaynon PS. Acute lymphocytic leukemia. In: Richard LG, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, editors. Wintrobe's clinical hematology. Baltimore: Lippincott Williams & Wilkins; 1999. pp 2241-2271.
2. Sklar CA. Overview of the effects of cancer therapies: The nature, scale and breadth of the problem. Acta Paediatr Suppl 1999;433:1-4.
3. Robison LL, Nesbit ME, Sather HN, et al. Height of children successfully treated for acute lymphoblastic leukemia: A report from the late effects study committee of children cancer study group. Med Pediatr Oncol 1985;13:14-21.
4. Clayton PE, Shalet SM, Morris-Jones PH, et al. Growth in children treated for acute lymphoblastic leukaemia. Lancet 1988;1:460-462.
5. Ildikó M, Mellander L, Lannering B, et al. A longitudinal study of growth and growth hormonal secretion in children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 1991;19:258-264.
6. Caruso-Nicoletti M, Mancuso M, Spadaro O, et al. Growth and growth hormone in children during and after therapy for acute lymphoblastic leukaemia. Eur J Pediatr 1993;152:730-733.
7. Hokken-Koelega ACS, van Doom JWD, Hählen K, et al. Long-term effects of treatment for acute lymphoblastic leucemia with and without cranial irradiation on growth and puberty: A comparative study. Pediatr Res 1993;33:577-582.
8. Katz JA, Pollock BH, Jacaruso D, et al. Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia. J Pediatr 1993;23:546-552.
9. Moëll C, Marky I, Hovi L, et al. Cerebral irradiation causes blunted pubertal growth in girls treated for acute leukemia. Med Pediatr Oncol 1994;22:375-379.
10. Davies HA, Didcock E, Didi M, et al. Growth, puberty and obesity after treatment for leukaemia. Acta Paediatr Suppl 1995;411:45-50.
11. Didcock E, Davies HA, Didi M, et al. Pubertal growth in young adult survivors of childhood leukemia. J Clin Oncol 1995;13:2503-2507.
12. Argüelles B, Barrios V, Buño M, et al. Anthropometric parameter and their relationship to serum growth hormone-binding protein and leptin levels in children with acute lymphoblastic leukemia: A prospective study. Eur J Endocrinol 2000;43:243-250.
13. Kirk JA, Stevens MM, Menser MA, et al. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet 1987;1:90-193.
14. Cicognani A, Cacciari E, Vecchi V, et al. Differential effects of 18- and 24-Gy cranial irradiation on growth rate and growth release in children with prolonged survival after acute lymphoblastic leukemia. Am J Dis Child 1988;142:1199-1202.
15. Logghe KA, Bourguignon JP, Craen M, et al. Factors contributing to the impairment of growth in children with acute lymphoblastic leukemia. Horm Res 1988;30:62-67.
16. Möel C, Garwicz S, Marky I, et al. Growth in children treated for acute lymphoblastic leukemia with and without prophylactic cranial irradiation. Acta Paediatr Scand 1988;77:688-692.
17. Davies HA, Didcock E, Didi M, et al. Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemia. Arch Dis Child 1994;70:472-475.
18. Timme J, Mittler U, Mohnike K, et al. Einfluß vershiedener therapieprotokolle auf das wachstum und die endgröße von Zinder mit akuter lymphoblastischer leukämie oder Non-Hodgkin-Lymphom. Klin Padiatr 1995;207:267-270.
19. Mohnike K, Dörffel W, Timme J, et al. Final heigth and puberty in 40 patients after antileukaemic treatment during childhood. Eur J Pediatr 1997;156:272-276.
20. Bennet JM, Catovsky D, Daniel M-T, et al. Proposals for the classification on the acute leukaemias. Br J Haematol 1976;33:451-458.
21. Riehm H, Gadner H, Henze G, et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies. Hematol Blood Transf 1990;33:439-450.
22. de Onis M, Habicht J-P. Anthropometric reference data for international use: Recommendations from the World Health Organization. Am J Clin Nutr 1996;64:50-658.
23. Hamill PVV, Terence AD, Johnson CL, et al. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979;32:607-629.
24. Dibley MJ, Goldsby JB, Staehling NW, et al. Development of normalized curves for the international growth reference: Historical and technical considerations. Am J Clin Nutr 1987;46:736-748.
25. World Health Organization. Working Group. Use and interpretation of anthropometric indicators of nutritional status. Bull World Health Org 1986;4:29-941.
26. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60.
27. Sainsbury CPO, Newcombe RG, Hughes IA. Weight gain and height velocity during prolonged first remission from acute lymphoblastic leukaemia. Arch Dis Child 1985;60:832-836.
28. Tamminga RYJ, Kamps WA, Drayer NM, et al. Longitudinal anthropometric study in children with acute lymphoblastic leukaemia. Acta Paediatr 1992;81:61-65.
29. Sklar CA, Mertens A, Walter A, et al. Final height after treatment for childhood acute lymphoblastic leukemia: Comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr 1993;123:59-64.
30. Birkebsk NH, Fisker S, Clausen N, et al. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 1998;30:351-356.
31. Dalton VK, Rue M, Silverman LB, et al. Height and weight in children treated for acute lymphoblastic leukemia: Relationship to CNS treatment. J Clin Oncol 2003;21:2953-2960.
32. Brämswig JH, Wegele M, von Lengerke HJ, et al. The effect of the number of fractions of cranial irradiation on growth in children with acute lymphoblastic leukaemia. Acta Paediatr Scand 1989;78:296-302.
33. Wells RJ, Foster MB, D'Ercole AJ, et al. The impact of cranial irradiation on growth of children with acute lymphoblastic leukemia. Am J Dis Child 1983;137:37-39.
34. Katz JA, Chambers B, Everhart C, et al. Linear growth in children with acute lympoblastic leukemia treated without cranial irradiation. J Pediatr 1991;118:575-578.
35. Ahmed SF, Wallace WHB, Kelnar CJH. An anthropometric study of children during intensive chemotherapy for acute lympoblastic leukaemia. Horm Res 1997;48:178-183.
36. Holm K, Nysom K, Hertz H, et al. Normal final height after treatment for acute lymphoblastic leukemia without irradiation. Acta Paediatr 1994;83:1287-1290.
37. Cicognani A, Cacciari E, Rosito P, et al. Longitudinal growth and final height in long-term survivors of childhood leukaemia. Eur J Pediatr 1994;153:726-730.
38. Cicognani A, Cacciari E, Carlá G, et al. Magnetic ressonance imaging of the pituitary area in children treated for acute lymphoblastic leukemia with low-dose (18 Gy) cranial irradiation. Relationships to growth and growth hormone secretion. Am J Dis Child 1992;146:1343-1348.
39. Bongers MEJ, Francken AB, Rouwé C, et al. Reduction of adult height in children acute lymphoblastic leukemia survivors after prophylactic cranial irradiation. Pediatr Blood Cancer 2005;45:139-143.
40. Shalet SM, Beardwell CG, Pearson D, et al. The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol 1976;5:287-290.
41. Brauner R, Czernichow P, Rappaport R. Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr 1986;108:332.
42. Brauner R, Prevot C, Roy MP, et al. Growth, growth hormone secretion and somatomedin C after cranial irradiation for acute lymphoblastic leukemia. Acta Endocrinol 1986;279:178-182.